Department of Radiation Oncology, University Hospital, Verona, Italy.
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e145-52. doi: 10.1016/j.ijrobp.2012.03.013. Epub 2012 Apr 28.
We report the results of a single-institution, phase II trial of accelerated partial breast irradiation (APBI) using a single dose of intraoperative electron radiation therapy (IOERT) in patients with low-risk early stage breast cancer.
A cohort of 226 patients with low-risk, early stage breast cancer were treated with local excision and axillary management (sentinel node biopsy with or without axillary node dissection). After the surgeon temporarily reapproximated the excision cavity, a dose of 21 Gy using IOERT was delivered to the tumor bed, with a margin of 2 cm laterally.
With a mean follow-up of 46 months (range, 28-63 months), only 1 case of local recurrence was reported. The observed toxicity was considered acceptable.
APBI using a single dose of IOERT can be delivered safely in women with early, low-risk breast cancer in carefully selected patients. A longer follow-up is needed to ascertain its efficacy compared to that of the current standard treatment of whole-breast irradiation.
我们报告了一项单中心、二期临床试验的结果,该试验在低危早期乳腺癌患者中使用单次术中电子放射治疗(IOERT)进行加速部分乳腺照射(APBI)。
一组 226 例低危、早期乳腺癌患者接受局部切除和腋窝管理(前哨淋巴结活检加或不加腋窝淋巴结清扫)。在外科医生暂时重新接近切除腔后,使用 IOERT 给予 21Gy 的剂量至肿瘤床,侧向边缘为 2cm。
中位随访 46 个月(范围 28-63 个月),仅报告 1 例局部复发。观察到的毒性被认为是可以接受的。
在仔细选择的患者中,单次 IOERT 可安全用于治疗早期、低危乳腺癌的 APBI。需要更长的随访时间来确定其与目前全乳照射标准治疗相比的疗效。